Hoylecohen LLC lowered its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 18.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 87,465 shares of the biopharmaceutical company’s stock after selling 20,396 shares during the quarter. Hoylecohen LLC’s holdings in Bristol-Myers […]